Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $450.00 | 3 | 89.0% |
| Food and Beverage | $55.62 | 3 | 11.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COMSORT, Inc | $450.00 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $55.62 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $150.00 | 1 | COMSORT, Inc ($150.00) |
| 2017 | $355.62 | 5 | COMSORT, Inc ($300.00) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2018 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2017 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 24 | 1,102 | 1,535 | $109,513 | $31,348 |
| 2020 | 54 | 3,724 | 36,394 | $1.1M | $298,000 |
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 59 | 71 | $17,821 | $4,846 | 27.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 49 | $17,787 | $4,783 | 26.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 42 | 59 | $16,284 | $4,001 | 24.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 24 | 24 | $9,600 | $2,792 | 29.1% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 11 | 20 | $9,980 | $2,777 | 27.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 127 | 184 | $6,072 | $1,934 | 31.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2021 | 92 | 102 | $4,794 | $1,526 | 31.8% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2021 | 121 | 174 | $3,306 | $1,046 | 31.6% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2021 | 28 | 111 | $3,219 | $1,032 | 32.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 79 | 124 | $2,976 | $957.05 | 32.2% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 47 | 64 | $2,692 | $872.32 | 32.4% |
| 86300 | Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | Office | 2021 | 35 | 40 | $2,600 | $815.19 | 31.4% |
| 82306 | Vitamin d-3 level | Office | 2021 | 25 | 25 | $2,300 | $715.52 | 31.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 27 | 29 | $1,508 | $487.20 | 32.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 63 | 75 | $1,502 | $485.25 | 32.3% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2021 | 12 | 23 | $1,495 | $478.63 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 106 | 157 | $1,413 | $468.36 | 33.1% |
| 82378 | Carcinoembryonic antigen (cea) protein level | Office | 2021 | 14 | 17 | $1,003 | $322.32 | 32.1% |
| 84550 | Uric acid level, blood | Office | 2021 | 44 | 59 | $826.00 | $262.94 | 31.8% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2021 | 29 | 37 | $814.00 | $260.44 | 32.0% |
| 84100 | Phosphate level | Office | 2021 | 31 | 40 | $600.00 | $185.68 | 30.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 17 | 18 | $504.00 | $162.36 | 32.2% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2021 | 18 | 21 | $273.00 | $89.67 | 32.8% |
| 85045 | Red blood count, automated test | Office | 2021 | 11 | 12 | $144.00 | $47.88 | 33.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 16 | 4,200 | $168,000 | $63,556 | 37.8% |
About Dr. Daniel Lieber, M.D
Dr. Daniel Lieber, M.D is a Hematology & Oncology healthcare provider based in North Conway, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356454623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Lieber, M.D has received a total of $505.62 in payments from pharmaceutical and medical device companies, with $150.00 received in 2018. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($450.00).
As a Medicare-enrolled provider, Lieber has provided services to 4,826 Medicare beneficiaries, totaling 37,929 services with total Medicare billing of $329,348. Data is available for 2 years (2020–2021), covering 78 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology, Hematology & Oncology
- Location North Conway, NH
- Active Since 08/17/2006
- Last Updated 01/10/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1356454623
Products in Payments
- KEYTRUDA (Biological) $450.00
- AFINITOR (Drug) $55.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.